DexCom Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy in 2026. On December 2, Morgan Stanley upgraded DexCom to ...

You know, it’s too rich a stock, and I do think the GLP-1s are going to have such a dramatic effect on their market. I don’t want to own the stock.

In late November Abbott—one of Dexcom’s main competitors— recalled some of its CGMs due to inaccurate low glucose readings. The recall affects approximately 3 million sensors and was caused by an ...

Senseonics earns a buy with Eversense 365 driving growth, Q3 revenue up 90% YoY, gross margin expansion, and Ascensia ...

The model, 34, and the comedian, 37, who are parents to daughter Elsie, two, became engaged when he popped the question in ...

MiniMed is pitching the breadth of its portfolio as an advantage over more focused rivals such as Dexcom and Insulet.

GlucoModicum today unveiled Sofio, which it labels the world's first needle-free glucose monitor based on magneto-hydrodynamics (MHD).

Rarer diabetes patients in Singapore can now receive up to 80% government subsidies for continuous glucose monitoring (CGM) ...

One of the main threads running through our most-read stories of 2025—as much as ever in the medtech industry writ large—is ...

Detailed price information for Idexx Laboratories (IDXX-Q) from The Globe and Mail including charting and trades.

Tandem Diabetes Care, Inc.’s TNDM impressive international expansion is expected to bolster growth in the upcoming quarters. The company’s impressive strategic initiatives provide a favorable ...

Diabeloop announced today that its DBLG2 algorithm for automated insulin delivery has received FDA 510(k) clearance.